Moderna cuts COVID vaccine sales forecast on supply woes, shares tumble

(Reuters) – Moderna Inc on Thursday cut the annual sales forecast for its COVID-19 vaccine citing short-term supply constraints that would push some vaccine deliveries out to next year, sending its shares down 15% before the bell.